THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

FDA advisers back Celebrex for children despite risks

By Diedtra Henderson
Globe Staff / November 30, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Children as young as 2 who suffer from arthritis can be treated with Celebrex , but to ensure the painkiller doesn't put them at later risk for heart attacks, their health should be tracked for decades, a Food and Drug Administration advisory panel said yesterday. (Full article: 503 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass